Biogen Inc. buy UBS Group AG
Start price
30.07.26
/
50%
€177.70
Target price
30.07.27
-
Performance (%)
1.96%
Price
22:25
€181.18
Summary
This prediction is currently active. With a performance of 1.96%, the BUY prediction by UBS_Group_AG for Biogen Inc. is trending in the right direction. This prediction currently runs until 30.07.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | -2.268% |
| iShares Core DAX® | 0.184% |
| iShares Nasdaq 100 | -0.770% |
| iShares Nikkei 225® | 0.733% |
| iShares S&P 500 | -0.166% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for BIIB provided by MarketBeat